Work

Real-world effectiveness and safety of adjuvant capecitabine in triple-negative breast cancer (TNBC) patients with residual disease following neoadjuvant chemotherapy.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.543

Authors: Anbarasan Sekar, Sanjana Malokar, Sushmita Rath, Prabhat Ghanshyam Bhargava, Anuradha Mehta, Ankush Santosh Dongare, George John, Shalaka Prakash Joshi, Karan Sood, Vaishnavi Lahane, Amar Deshpande, Tabasum Wadasadawala, Nitin Shetty, Asawari Patil, Chaitali Nashikkar, Pallavi Appa Parab, Salma S., Sudeep Gupta

Institutions: Homi Bhabha National Institute, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Hospital

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162500960

Cites:

Cited by:

Related to: